All news
EMA approves two combination-treatments for an aggressive oesophageal cancer
18 March 2022EMA recommends approval for nivolumab (Opdivo) plus ipilimumab (Yervoy) as a first-line treatment for adults with advanced oesophageal squamous cel...
New Reports Support Improved Cancer Screening Programmes in Europe
9 March 2022Two new reports provide recommendations on digestive cancer screening to the European Commission
...
Getting Citizens to Seek Answers on Colorectal Cancer – European Colorectal Cancer Awareness Month Launches
24 February 2022European Colorectal Cancer Awareness Month #ECCAM2022 Campaign Launches with EU Policy Event
...
Recognising Hereditary and Rare Cancers – An Overview from our Member Organisation FAPA
24 February 2022Rare Diseases in Focus – An Overview of FAP and Lynch Syndrome from our Belgian Member FAPA
...
European Parliament Endorses the Final Report of the BECA Special Committee
23 February 2022European Parliament Endorses Beating Cancer Plan
...
Study Shows – DNA Test Prior to Chemotherapy Can Prevent Serious Side Effects for Some Colorectal Cancer Patients
23 February 2022Study Shows – DNA Test Prior to Chemotherapy Can Prevent Serious Side Effects for Colorectal Cancer Patients
...
DiCE CEO Speaks at Event Marking 15 Years of First Biosimilar Approval in Europe
21 February 2022Zorana Maravic presented the view of the digestive cancer patient community at the February event “15 Years of Biosimilars: Improving Equitab...
Digestive Cancers Europe Participates in EU4Health 2022 Funding Calls
21 February 2022The EU4Health 2022 work programme was officially launched by the European Commission on January 14.
...
Research Finds Viable Marker for the Early Diagnosis of Most Common Type of Pancreatic Cancer
21 February 2022Teams of researchers from Spain have identified a new viable marker for early diagnosis in the most common type of pancreatic cancer, pancreatic du...